Astera Labs, Inc. (NASDAQ:ALAB) Stock Holdings Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 50.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,360,467 shares of the company's stock after acquiring an additional 792,153 shares during the quarter. JPMorgan Chase & Co. owned approximately 1.49% of Astera Labs worth $312,644,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ALAB. Tidal Investments LLC lifted its holdings in shares of Astera Labs by 81.8% during the third quarter. Tidal Investments LLC now owns 45,298 shares of the company's stock valued at $2,373,000 after purchasing an additional 20,388 shares during the last quarter. Proficio Capital Partners LLC grew its stake in Astera Labs by 1.8% during the fourth quarter. Proficio Capital Partners LLC now owns 21,626 shares of the company's stock valued at $2,864,000 after acquiring an additional 390 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Astera Labs during the 3rd quarter valued at approximately $530,000. State Street Corp lifted its holdings in shares of Astera Labs by 173.1% in the 3rd quarter. State Street Corp now owns 698,467 shares of the company's stock valued at $36,593,000 after acquiring an additional 442,698 shares during the last quarter. Finally, Peregrine Investment Management Inc. purchased a new position in Astera Labs during the fourth quarter worth $10,701,000. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Northland Capmk upgraded shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 28th. Northland Securities upgraded Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 target price on the stock in a research note on Tuesday, January 28th. Barclays boosted their price objective on Astera Labs from $87.00 to $135.00 and gave the company an "overweight" rating in a research report on Friday, January 17th. Stifel Nicolaus increased their price objective on Astera Labs from $100.00 to $150.00 and gave the company a "buy" rating in a research note on Monday, January 6th. Finally, Craig Hallum boosted their price target on shares of Astera Labs from $105.00 to $125.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. One analyst has rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $112.77.

Remove Ads

Astera Labs Price Performance

Shares of ALAB stock traded down $2.74 during trading hours on Friday, reaching $52.94. 5,757,559 shares of the stock were exchanged, compared to its average volume of 3,708,884. The firm has a market capitalization of $8.58 billion and a P/E ratio of -30.60. The business's fifty day moving average is $78.49 and its two-hundred day moving average is $90.43. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, CEO Jitendra Mohan sold 350,680 shares of the business's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total transaction of $31,389,366.80. Following the completion of the sale, the chief executive officer now owns 2,353,655 shares in the company, valued at approximately $210,675,659.05. The trade was a 12.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Manuel Alba sold 63,000 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $63.37, for a total value of $3,992,310.00. Following the completion of the sale, the director now owns 444,863 shares of the company's stock, valued at approximately $28,190,968.31. This represents a 12.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 633,990 shares of company stock valued at $54,235,012.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.